Mobile menu
Home » Celiac Disease Research » Drug Development News

Celiac Disease Research News

Stay up to date on advances in the development of alternative, non-dietary treatments in the celiac disease field. These articles from the Beyond Celiac Research News feed highlight the latest news and past milestones in the journey to find new treatments – or even a cure – for celiac disease. Note:  Prior to December 2015, Beyond Celiac was known as the National Foundation for Celiac Awareness. Learn more about the name change here.  

LILY Study launches to test monoclonal antibody treatment for celiac disease 

This new phase 1 trial does not include a gluten challenge


Celiac disease drugs show progress

Three companies developing celiac disease drugs gave updates on their treatments recently at Digestive Disease Week (DDW).


Takeda launches the Illuminate-062 Study, a Phase 2 clinical trial of a medicine designed to help improve control of celiac disease

The study is looking adults with celiac disease who are having problems controlling their celiac disease symptoms


Cystic fibrosis patients changed the future of the disease — can celiac disease emulate their success?

Cystic fibrosis patients banded together and changed the future for those living with the disease. Can increased patient participation produce similar results for celiac disease?


PRV-015: A monoclonal antibody treatment in late-stage trials for celiac disease

Monoclonal antibodies can be used for treating many different types of disease and are being studied in celiac disease after showing proof-of-concept in earlier trials


Is Provention Bio's Phase 2 PROACTIVE Celiac Study right for you?

PRV-015 has previously been studied for its potential to reduce symptoms and inflammation triggered by gluten in people with celiac disease.


Immunogenx, Inc. Continues Latiglutenase Development and Commitment to Celiac Disease Research with the Solutions for Celiac Study

Latiglutenase development continues with initial CeliacShield™ study results and ongoing Solutions for Celiac™ clinical study actively recruiting participants


Beyond Celiac Drives Recruitment for Promising Anokion Clinical Trial

Celiac disease community is an integral part of research into this potential immune tolerance treatment


Larazotide Acetate launches phase 3 trial

Recruitment of symptomatic participants in the first celiac disease Phase 3 clinical trial continues


New celiac disease drug candidate, KAN-101, in Phase 1 clinical trials

New potential treatment for celiac disease aims to re-educate the immune system so it does not react to gluten


Phase 2 study relaunching in November

Celiac disease study postponed due to COVID-19 is relaunching in November


Launch of new late-stage Phase 2b study for celiac disease patients who continue to have symptoms while on a gluten-free diet

A trial that launched in late August will test PRV-015 in symptomatic celiac disease patients


New Phase 2 Clinical Trial for Symptomatic Celiac Disease Patients Launches

Testing of latiglutenase to relieve symptoms in celiac disease patients continues with the launch of a clinical trial in December


DDW research highlights celiac disease symptom disconnect

Studies also show evidence of how frquently patients are exposed to gluten, especially on the weekends


Online alternative medicine advice about celiac disease often incorrect

A new study found incorrect or unproven information on diagnosis and treatment on majority of alternative medicine websites


New guidelines for feeding infants at risk for celiac disease

Limiting the amount of gluten-containing food might help prevent celiac disease from developing


At-home test for celiac disease gets scientific review

Study details accuracy of test in diagnosis and monitoring of celiac disease


Phase 2 Clinical Trial for Celiac Drug Candidate is Recruiting Participants

Testing of a drug candidate used in conjunction with a gluten-free diet that is designed to help protect people with celiac disease against inadvertent gluten exposure launches


Why does someone get celiac disease?

A new virus has been added to the list of potential reasons celiac disease develops


Upending some beliefs about celiac disease

Experts weigh in on how views are changing


FDA fast tracks celiac disease vaccine

Designation highlights need for new treatments for patients


Getting to the bottom of persistent celiac disease symptoms

Refractory celiac disease is rarely the cause so physicians need to rule out more common reasons


At-Home Test for Celiac Disease Launches

Results are designed to be shared with your doctor for a definitive diagnosis


Fatigue is often found in celiac disease

But a new study says it needs to be better understood and treated


Breaking the cycle of underfunded celiac disease research

Beyond Celiac joins SSCD to attract investigators to the field

1 2 4 5

Think you may have celiac disease?

Symptoms Checklist